Antineoplaston Therapy in Treating Patients With Low-Grade Non-Hodgkin's Lymphoma

Summary

Current therapies for Low-grade Non-Hodgkin's Lymphoma provide limited benefit to the patient. The anti-cancer properties of Antineoplaston therapy suggest that it may prove beneficial in the treatment of Low-grade Non-Hodgkin's Lymphoma. PURPOSE: This study is being performed to determine the effects (good and bad) that Antineoplaston therapy has on patients with Low-grade Non-Hodgkin's Lymphoma.

Timeline

Start

1996-03-06

Primary completion

2003-09-13

Completion

2003-09-13

Drugs

Indications